Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M415Revenue $M5.2Net Margin (%)-695.6Z-Score1.3
Enterprise Value $M415EPS $-0.6Operating Margin %-967.8F-Score3
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-977.5Higher ROA y-yY
Price/Book11.810-y EBITDA Growth Rate %33.6Quick Ratio4.5Cash flow > EarningsN
Price/Sales62.35-y EBITDA Growth Rate %48.5Current Ratio4.6Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-58.4Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)-183.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M83.2ROI % (ttm)-119.2Gross Margin Increase y-yY

Gurus Latest Trades with BTX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

BTX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


BTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Russell Angus C.Director 2014-12-12Sell0$0view
Cartt Stephen LaHueDirector 2014-11-04Sell0$0view
SCHLACHET DAVIDDirector 2014-10-08Buy32,050$3.1261.86view
FARRELL STEPHEN CDirector 2014-10-08Buy32,050$3.1261.86view
Peabody RobertSr. VP, COO, and CFO 2014-07-22Sell100,000$2.6590.57view
WEST MICHAEL DCEO 2014-07-22Sell270,000$2.6590.57view
BROADWOOD PARTNERS LPDirector, 10% Owner 2014-07-22Buy370,000$2.6590.57view
TEW WILLIAM P PHDChief Commercial Officer 2014-06-17Sell30,000$3.0764.5view
BROADWOOD PARTNERS LPDirector, 10% Owner 2014-06-16Buy1,000,000$2.5102view
BROADWOOD PARTNERS LPDirector, 10% Owner 2014-05-16Buy300,000$2.45106.12view

Press Releases about BTX :

    Quarterly/Annual Reports about BTX:

    News about BTX:

    Articles On GuruFocus.com
    Weekly CFO Buys Highlight: BTX, CWST, BKSC, STAG Jun 27 2011 
    Weekly CEO Buys Highlight: PCYC, HLX, FSC, CREG, BTX Jun 26 2011 

    More From Other Websites
    OncoCyte Announces Availability of Abstracts With New Clinical Data From Studies of PanC-Dx™... Mar 26 2015
    OncoCyte Announces Availability of Abstracts With New Clinical Data From Studies of PanC-Dx™... Mar 20 2015
    BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure Mar 20 2015
    BIOTIME INC Financials Mar 18 2015
    How Apple ResearchKit Could Change Science Forever Mar 18 2015
    BIOTIME INC Files SEC form 8-K, Entry into a Material Definitive Agreement Mar 12 2015
    BioTime, Inc. Reports Fourth Quarter and Fiscal Year End 2014 Financial Results and Recent Corporate... Mar 11 2015
    BioTime reports 4Q loss Mar 11 2015
    BioTime reports 4Q loss Mar 11 2015
    BioTime, Inc. Reports Fourth Quarter and Fiscal Year End 2014 Financial Results and Recent Corporate... Mar 11 2015
    BIOTIME INC Files SEC form 8-K, Results of Operations and Financial Condition Mar 11 2015
    BIOTIME INC Files SEC form 10-K, Annual Report Mar 11 2015
    Asterias Biotherapeutics Reports Fourth Quarter and Full Year 2014 Financial and Operating Results Mar 10 2015
    BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure Mar 10 2015
    Icahn School of Medicine at Mount Sinai and LifeMap Solutions Launch Asthma Study for iPhone Mar 09 2015
    BioTime Announces First Patient Treated in Pivotal Clinical Trial of Renevia™ for HIV-Associated... Mar 02 2015
    ESI BIO – A Division of BioTime, Inc., Announces Alliance Agreement with Pivotal Scientific Ltd... Mar 02 2015
    LifeMap Sciences Partners with Toldot Genetics to Support Next Generation Sequencing Variant... Mar 02 2015
    BioTime Announces First Patient Treated in Pivotal Clinical Trial of Renevia™ for HIV-Associated... Feb 24 2015
    BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure Feb 24 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK